AngioSoma (OTCBB: SOAN) prides itself on our technology, patents, team and potential medical breakthroughs. Below please find our May 2021 Investment Slide Deck for review.
Please contact firstname.lastname@example.org with any questions.
AngioSoma, Inc. is a publicly traded clinical stage biotechnology company with the OTCBB ticker symbol SOAN. The company has a patented formulation of currently available drugs which have been shown, in our formulation, to enhance the quality of life for Multiple Sclerosis patients.
AngioSoma does not provide forward-looking information and will consistently update our website as appropriate. If you would like to reach out to our investor relations department, please contact us below or email email@example.com
Investor Relations Contact
Standard Registrar and Transfer Company
440 East 400 South, Suite 200
Salt Lake City, UT 84111
Phone: 801-571-8844 or 801-596-2150